ID

13010

Description

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00003746

Link

https://clinicaltrials.gov/show/NCT00003746

Keywords

  1. 1/11/16 1/11/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

January 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Leukemia NCT00003746

Eligibility Leukemia NCT00003746

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00003746
Criteria
Description

Criteria

histologically confirmed classic form or prolymphocytic variant hairy cell leukemia (hcl)
Description

Hairy cell leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023443
newly diagnosed hcl or progressive disease after prior treatment
Description

newly diagnosed hcl or progressive disease after prior treatment

Data type

boolean

Alias
UMLS CUI [1]
C0023443
age: 18 and over
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
performance status: nci 0-2
Description

performance status

Data type

boolean

Alias
UMLS CUI [1]
C1518965
life expectancy: at least 3 months
Description

life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
hepatic: bilirubin no greater than 2.0 mg/dl
Description

bilirubin

Data type

boolean

Alias
UMLS CUI [1]
C1278039
renal: creatinine no greater than 2.3 mg/dl
Description

creatinine

Data type

boolean

Alias
UMLS CUI [1]
C0201976
hiv negative
Description

hiv

Data type

boolean

Alias
UMLS CUI [1]
C0019682
not pregnant
Description

pregnant

Data type

boolean

Alias
UMLS CUI [1]
C0032961
no other prior or concurrent malignancy except carcinoma in situ of the cervix or basal or squamous cell carcinoma of the skin
Description

malignancy

Data type

boolean

Alias
UMLS CUI [1]
C0006826
prior concurrent therapy: at least 4 weeks since any prior therapy and recovered
Description

prior concurrent therapy

Data type

boolean

Alias
UMLS CUI [1]
C0087111
chemotherapy: no concurrent cytoreductive therapy, no prior cladribine
Description

chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920

Similar models

Eligibility Leukemia NCT00003746

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00003746
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Hairy cell leukemia
Item
histologically confirmed classic form or prolymphocytic variant hairy cell leukemia (hcl)
boolean
C0023443 (UMLS CUI [1])
newly diagnosed hcl or progressive disease after prior treatment
Item
newly diagnosed hcl or progressive disease after prior treatment
boolean
C0023443 (UMLS CUI [1])
age
Item
age: 18 and over
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status: nci 0-2
boolean
C1518965 (UMLS CUI [1])
life expectancy
Item
life expectancy: at least 3 months
boolean
C0023671 (UMLS CUI [1])
bilirubin
Item
hepatic: bilirubin no greater than 2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
creatinine
Item
renal: creatinine no greater than 2.3 mg/dl
boolean
C0201976 (UMLS CUI [1])
hiv
Item
hiv negative
boolean
C0019682 (UMLS CUI [1])
pregnant
Item
not pregnant
boolean
C0032961 (UMLS CUI [1])
malignancy
Item
no other prior or concurrent malignancy except carcinoma in situ of the cervix or basal or squamous cell carcinoma of the skin
boolean
C0006826 (UMLS CUI [1])
prior concurrent therapy
Item
prior concurrent therapy: at least 4 weeks since any prior therapy and recovered
boolean
C0087111 (UMLS CUI [1])
chemotherapy
Item
chemotherapy: no concurrent cytoreductive therapy, no prior cladribine
boolean
C0392920 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial